Literature DB >> 7885124

Is proximal demarcation of ulcerative colitis determined by the territory of the inferior mesenteric artery?

M I Hamilton1, R Dick, L Crawford, N P Thompson, R E Pounder, A J Wakefield.   

Abstract

The sharp demarcation between diseased and normal mucosa often observed in ulcerative colitis remains unexplained by current hypotheses of disease pathogenesis. To investigate whether this demarcation occurs at the watershed of vascular territories, the colonic arterial anatomy of 10 patients with ulcerative colitis was studied by in-vitro angiography and macroscopic and histological examination of total colectomy specimens. Of the 10 perfusion-fixed colectomy specimens studied, 7 had pancolitis associated with a complete marginal artery (Arteria marginalis coli) that spanned the entire length of the large bowel. 3 specimens had sharply demarcated disease in which the marginal artery arose from the inferior mesenteric artery and ended abruptly at the point of mucosal demarcation. The colon proximal to this point was histologically normal. These findings suggest that the proximal extent of colitis is determined by the limit of the marginal artery. We suggest that some characteristic of the mucosal microvasculature in the territory of the inferior mesenteric artery, possibly embryological in origin, predisposes the dependent colon to develop ulcerative colitis.

Entities:  

Mesh:

Year:  1995        PMID: 7885124     DOI: 10.1016/s0140-6736(95)90867-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

Review 1.  Vascular anatomy in gastrointestinal inflammation.

Authors:  A Anthony
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

2.  Ulcerative colitis extent varies with time but endoscopic appearances may be deceptive.

Authors:  J M Rhodes
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

3.  Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation.

Authors:  Petros Zezos; Georgia Papaioannou; Nikolaos Nikolaidis; Themistoclis Vasiliadis; Olga Giouleme; Nikolaos Evgenidis
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

4.  Altered expression of mucins throughout the colon in ulcerative colitis.

Authors:  J E Smithson; A Campbell; J M Andrews; J D Milton; R Pigott; D P Jewell
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

Review 5.  Immunopathology of human inflammatory bowel disease.

Authors:  P Brandtzaeg; G Haraldsen; J Rugtveit
Journal:  Springer Semin Immunopathol       Date:  1997

6.  Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis.

Authors:  M Vecchi; E Sacchi; S Saibeni; G Meucci; L Tagliabue; F Duca; R De Franchis
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

Review 7.  Inflammatory bowel disease and thromboembolism.

Authors:  Petros Zezos; Georgios Kouklakis; Fred Saibil
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

8.  Evidence against a systemic arterial defect in patients with inflammatory bowel disease.

Authors:  Luke A Neill; Christine M Saundry; Neil H Hyman; George C Wellman
Journal:  J Surg Res       Date:  2014-04-16       Impact factor: 2.192

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.